V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161729 | 20062579 | 1.57 | 61.2 | Neo-adjuvant (N) | 2017-07-13 | 2017-07-13 | ECX | 2 | N | ECX | 101557493 |
| 20161743 | 20062580 | 1.6 | 64.3 | Palliative (P) | 2016-11-24 | 2016-11-24 | ECX | 02 | N | ECX | 100120472 |
| 20161748 | 20062581 | 1.69 | 96.6 | Palliative (P) | 2018-01-06 | 2018-01-15 | ECX | N | N | ECX | 101554952 |
| 20161750 | 20062582 | 1.73 | 99 | Neo-adjuvant (N) | 2019-07-23 | 2019-08-11 | ECX | N | N | ECX | 101090100 |
| 20161753 | 20062583 | 1.71 | 75.6 | Neo-adjuvant (N) | 2016-06-24 | 2016-06-24 | ECX | N | N | ECX | 101370332 |
| 20161756 | 20062584 | 1.65 | 66.7 | null | 2017-12-10 | 2017-12-18 | Gemcitabine + Capecitabine | N | null | ECX | 101070160 |
| 20161766 | 20062585 | 1.6 | 96 | Neo-adjuvant (N) | 2019-08-15 | 2019-08-23 | ECX | N | N | ECX | 100241530 |
| 20161767 | 20062586 | 1.69 | 55 | Neo-adjuvant (N) | 2019-07-21 | 2019-07-29 | ECX | N | N | ECX | 101230962 |
| 20161771 | 20062587 | 1.65 | 42.6 | Palliative (P) | 2018-04-25 | 2018-04-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101013310 |
| 20161778 | 20062588 | 1.72 | 62.4 | Palliative (P) | 2016-11-25 | 2016-12-07 | ECX | 02 | N | ECX | 100390982 |
| 20161780 | 20062589 | 1.67 | 95 | Adjuvant (A) | 2017-05-27 | 2017-06-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101114107 |
| 20161785 | 20062590 | 1.61 | 74.2 | Curative (C) | 2017-04-25 | 2017-05-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101065263 |
| 20161786 | 20062591 | 1.68 | 62 | Adjuvant (A) | null | 2017-06-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100833115 |
| 20161787 | 20062592 | 1.85 | 89.25 | Neo-adjuvant (N) | 2016-03-26 | 2016-04-04 | ECX | N | null | ECX | 100269021 |
| 20161789 | 20062593 | 1.9 | 53.7 | Palliative (P) | 2019-09-30 | 2019-10-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100998484 |
| 20161794 | 20062594 | 1.62 | 76.6 | Neo-adjuvant (N) | 2019-06-04 | 2019-06-15 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101843135 |
| 20161797 | 20062595 | 1.6 | 58 | Curative (C) | 2016-05-24 | 2016-05-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100711563 |
| 20161798 | 20062596 | 1.75 | 83 | Neo-adjuvant (N) | 2017-06-05 | 2017-06-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101449763 |
| 20161801 | 20062597 | 1.72 | 91 | Palliative (P) | 2016-08-17 | 2016-08-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101813666 |
| 20161807 | 20062598 | 1.7 | 85.1 | Palliative (P) | 2019-09-25 | 2019-10-03 | ECX | N | N | ECX | 100455719 |
| 20161813 | 20062599 | 1.49 | 62 | Palliative (P) | 2019-08-02 | 2019-08-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100173756 |
| 20161815 | 20062600 | null | 51.2 | Palliative (P) | 2018-05-28 | 2018-05-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100409688 |
| 20161829 | 20062601 | 1.68 | 62.95 | Adjuvant (A) | 2018-09-16 | 2018-10-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100710687 |
| 20161834 | 20062602 | 1.61 | 64 | 02 | 2019-09-25 | 2019-10-03 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101474542 |
| 20161837 | 20062603 | 1.6 | 92 | Palliative (P) | 2019-01-20 | 2019-01-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100249887 |
| 20161840 | 20062604 | 1.53 | null | Palliative (P) | 2016-08-26 | 2016-09-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101418704 |
| 20161860 | 20062605 | 1.6 | 74.4 | Adjuvant (A) | 2020-02-01 | 2020-02-05 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101391929 |
| 20161864 | 20062606 | 1.82 | 82.05 | Neo-adjuvant (N) | 2016-08-05 | 2016-08-18 | ECX | N | N | ECX | 101030445 |
| 20161865 | 20062607 | 1.82 | 82.3 | Palliative (P) | 2018-01-07 | 2018-01-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100359233 |
| 20161866 | 20062608 | 1.65 | 64.4 | Palliative (P) | 2018-08-22 | 2018-08-24 | ECX | N | N | ECX | 101035676 |
| 20161867 | 20062609 | 1.75 | 77.85 | Palliative (P) | 2018-09-01 | 2018-09-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100279457 |
| 20161877 | 20062610 | 1.53 | 66.9 | Neo-adjuvant (N) | 2018-02-20 | 2018-03-19 | ECX | N | N | ECX | 100602836 |
| 20161888 | 20062611 | 1.68 | 71 | Palliative (P) | null | 2017-12-11 | ECX | null | N | ECX | 100328495 |
| 20161889 | 20062612 | 1.7 | 62 | Palliative (P) | 2017-09-07 | 2017-09-13 | ECX | 2 | N | ECX | 100504001 |
| 20161891 | 20062613 | 1.78 | 59.9 | Neo-adjuvant (N) | 2018-01-25 | 2018-02-08 | ECX | N | N | ECX | 100489176 |
| 20161894 | 20062614 | 1.77 | 59.4 | Palliative (P) | 2019-08-20 | 2019-08-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100175060 |
| 20161896 | 20062615 | 1.73 | 51.8 | Adjuvant (A) | 2017-11-04 | 2017-11-04 | ECX | 02 | N | ECX | 100580725 |
| 20161897 | 20062616 | 1.8 | 66.8 | Neo-adjuvant (N) | 2016-03-06 | 2016-03-20 | ECX | 02 | N | ECX | 100233319 |
| 20161898 | 20062617 | 1.6 | 60 | Adjuvant (A) | null | 2017-03-07 | ECX | N | null | ECX | 100225567 |
| 20161905 | 20062618 | 1.78 | 80.3 | Adjuvant (A) | 2017-01-27 | 2017-01-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100174345 |
| 20161915 | 20062619 | 1.79 | 60.7 | Neo-adjuvant (N) | 2018-04-14 | 2018-04-14 | ECX | N | N | ECX | 100967533 |
| 20161918 | 20062620 | 1.72 | 87.4 | Adjuvant (A) | null | 2019-03-13 | CAPECITABINE + GEMCITABINE | null | N | CAPECITABINE + GEMCITABINE | 100560036 |
| 20161921 | 20062621 | 1.46 | 89.6 | Adjuvant (A) | 2017-05-15 | 2017-05-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101566039 |
| 20161923 | 20062622 | 1.74 | 76.8 | Neo-adjuvant (N) | 2016-12-06 | 2016-12-15 | ECX | N | N | ECX | 100018328 |
| 20161931 | 20062623 | 1.69 | 89.6 | Palliative (P) | 2016-05-01 | 2016-05-13 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100904445 |
| 20161934 | 20062624 | 1.73 | null | Palliative (P) | 2018-08-23 | 2018-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101671212 |
| 20161942 | 20062625 | 1.69 | 98.2 | Neo-adjuvant (N) | 2016-03-18 | 2016-03-28 | ECX | N | N | ECX | 100515246 |
| 20161950 | 20062626 | 1.73 | 72 | Neo-adjuvant (N) | 2017-05-15 | 2017-05-17 | ECX | Y | N | ECX | 100432477 |
| 20161955 | 20062627 | 1.58 | 79 | Palliative (P) | 2017-02-18 | 2017-02-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100831769 |
| 20161964 | 20062628 | 1.83 | 83.9 | Curative (C) | 2019-08-04 | 2019-08-17 | ECX | N | N | ECX | 100900977 |